Definitive Analysis
Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial

GE HealthCare Technologies Inc.

Intrinsic Value Analysis (Discounted Cash Flow)Industry: Medical - Healthcare Information ServicesSector: Healthcare

Fair Value Summary

Current Price$56.00
5Y Range95.52 – 141.79
5Y Selected118.65
(-) Safety Margin82.75%
5Y Buy Price$20.47
Upside (to Buy Price)-63.45%
10Y Range101.56 – 146.76
10Y Selected124.16
(-) Safety Margin82.75%
10Y Buy Price$21.42
Upside (to Buy Price)-61.75%

Company Predictability & Safety

MetricValue
Revenue R2 (5Y)0.9522
Revenue R2 (10Y)0.9649
Net Income R2 (5Y)0.4893
Net Income R2 (10Y)0.1133
EBITDA R2 (5Y)0.4456
EBITDA R2 (10Y)0.0209
FCF R2 (5Y)0.2637
FCF R2 (10Y)0.2635
Safety Score0.1725

DA 10-Year Projection

Metric2025202620272028202920302031203220332034
% Growth2.77%2.91%3.04%3.18%3.32%3.45%3.59%3.73%3.86%4.00%
Revenue20,217.2820,805.2621,438.7322,120.7422,854.6423,644.0724,493.0425,405.9226,387.4827,442.98
EBITDA3,352.083,449.573,554.603,667.683,789.363,920.254,061.014,212.374,375.114,550.12
D&A-693.47-713.64-735.37-758.77-783.94-811.02-840.14-871.45-905.12-941.32
EBIT2,658.602,735.922,819.232,908.913,005.423,109.233,220.873,340.923,469.993,608.79
Pro forma Taxes-94.48-97.23-100.19-103.37-106.80-110.49-114.46-118.73-123.31-128.24
NOPAT2,564.122,638.702,719.042,805.542,898.622,998.743,106.413,222.193,346.683,480.55
Capital Expenditures-359.26-369.71-380.97-393.09-406.13-420.16-435.24-451.47-468.91-487.66
NWC Investment59.5164.1769.1474.4480.1086.1692.6699.63107.13115.20
(+) D&A693.47713.64735.37758.77783.94811.02840.14871.45905.12941.32
Free Cash Flow2,957.853,046.803,142.583,245.653,356.533,475.763,603.973,741.813,890.024,049.41
Diluted Shares Outstanding458,250,000.00458,250,000.00458,250,000.00458,250,000.00458,250,000.00458,250,000.00458,250,000.00458,250,000.00458,250,000.00458,250,000.00

Discounting Periods

MetricDec-25Dec-26Dec-27Dec-28Dec-29Dec-30Dec-31Dec-32Dec-33Dec-34
Period Start9/30/251/1/261/1/271/1/281/1/291/1/301/1/311/1/321/1/331/1/34
Period End12/31/2512/31/2612/31/2712/31/2812/31/2912/31/3012/31/3112/31/3212/31/3312/31/34
Mid-Point11/15/257/2/267/2/277/1/287/2/297/2/307/2/317/1/327/2/337/2/34
Time (t)0.100.461.462.463.464.465.466.467.468.46
Valuation Date1/16/26

Base Case Projected Flows

WACC: 9.10%Terminal Growth: 2.48%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.880.810.740.680.620.570.520.48
PV UFCF2,932.202,927.172,767.412,619.832,483.382,357.152,240.272,131.992,031.601,938.48
Raw: 51,996.44
36,831.48
Raw: 62,729.99
28,749.93

Base Case Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value50,561.4853,179.43
(-) Net Debt-1,409.50-1,409.50
Equity Value51,970.9854,588.93
(/) Shares Out458.25458.25
Fair Value$113.41$119.12
(-) Safety Margin82.75%82.75%
Buy Price$19.56$20.55
Current Price$56.00$56.00
Upside (to Buy Price)-65.07%-63.31%

Conservative Projected Flows

WACC: 10.10%Terminal Growth: 1.98%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.870.790.720.650.590.540.490.44
PV UFCF2,929.532,914.912,730.792,561.682,406.212,263.152,131.402,009.961,897.921,794.48
Raw: 42,179.13
28,817.15
Raw: 50,886.10
21,490.94

Conservative Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value42,360.2745,130.97
(-) Net Debt-1,409.50-1,409.50
Equity Value43,769.7746,540.47
(/) Shares Out458.25458.25
Fair Value$95.52$101.56
(-) Safety Margin82.75%82.75%
Buy Price$16.48$17.52
Current Price$56.00$56.00
Upside (to Buy Price)-70.58%-68.72%

Aggressive Projected Flows

WACC: 8.10%Terminal Growth: 2.98%
Metric2025202620272028202920302031203220332034TV (5y)TV (10y)
Discount Factor0.990.960.890.830.760.710.650.600.560.52
PV UFCF2,934.912,939.602,804.872,679.852,563.782,455.972,355.792,262.662,176.072,095.53
Raw: 67,571.10
49,641.29
Raw: 81,519.69
40,574.79

Aggressive Valuation

5-Year Horizon10-Year Horizon
UFCFUFCF
Enterprise Value63,564.3065,843.82
(-) Net Debt-1,409.50-1,409.50
Equity Value64,973.8067,253.32
(/) Shares Out458.25458.25
Fair Value$141.79$146.76
(-) Safety Margin82.75%82.75%
Buy Price$24.46$25.32
Current Price$56.00$56.00
Upside (to Buy Price)-56.32%-54.79%

Reverse DCF: Market Implied Growth

Current Price$56.00
WACC Used9.1%
IMPLIED REVENUE GROWTH111.11%
Metric2027202820292030203120322033203420352036
Implied Revenue42,757.0290,266.27190,565.19402,310.74849,336.321,793,072.153,785,435.347,991,602.9616,871,432.7935,618,041.30
Constant Implied Growth111.11%111.11%111.11%111.11%111.11%111.11%111.11%111.11%111.11%111.11%
Implied Free Cash Flow4.289.0319.0640.2384.93179.31378.54799.161,687.143,561.80
Discount Factor0.930.810.740.680.620.570.520.480.440.40
Present Value of Implied FCF3.987.2914.1027.2852.80102.16197.70382.56740.301,432.54

Rolling Historical DCF (Backtest)

Valuation based on actual realized growth.
Error: Rolling DCF Data Not Available
Debug Info: Read Error

Monte Carlo Simulation (1,000 Iterations)

Mean Fair Value
$122.81
Median
$119.49
10th Percentile
$101.23
90th Percentile
$148.69

Fair Value Distribution

$86.27 - $93.94
26
$93.94 - $101.60
79
$101.60 - $109.27
157
$109.27 - $116.93
176
$116.93 - $124.60
173
$124.60 - $132.26
133
$132.26 - $139.92
87
$139.92 - $147.59
61
$147.59 - $155.25
44
$155.25 - $162.92
27
$162.92 - $170.58
16
$170.58 - $178.25
7
$178.25 - $185.91
4
$185.91 - $193.57
2
$193.57 - $201.24
2
$201.24 - $208.90
3
$208.90 - $216.57
1
$216.57 - $224.23
0
$224.23 - $231.90
1
$231.90 - $239.56
1